Regulatory and Clinical Requirements for Prescription to OTC Switches in USA and India
Abstract:In this article, Mithun Raja B. and Raghavendra Rao K., explain the clinical and regulatory requirements governing the process of prescription to OTC switches in USA and India. The article discusses the reasons for these switches, the process itself and what regulatory agencies in both countries require from pharmaceutical manufacturers.
Click here to download the file
Compliance Trainings
Pregnancy in the Workplace: Strategies to Protect Your Organization from Pregnancy Discrimination Claims
By - Christopher W. Olmsted
On Demand Access Anytime
By - Christopher W. Olmsted
On Demand Access Anytime
How to Vet an IRB: Expose and Fix Problems Before They Threaten Your Trial
By - Madhavi Diwanji
On Demand Access Anytime
By - Madhavi Diwanji
On Demand Access Anytime
Compliance Standards
You Recently Viewed
